Work

Response‐adapted Treatment With Nivolumab and Brentuximab Vedotin in Young Patients With Relapsed/refractory Classical Hodgkin Lymphoma: Checkmate 744 Subgroup Analyses

Year: 2019

Type: article

Source: Hematological Oncology

DOI: 10.1002/hon.26_2629

Authors: K.M. Kelly, S. Daw, C. Mauz‐Körholz, M. Mascarin, G. Michel, S. Cooper, A. Beishuizen, K.J. Leger, A. Garaventa, S. Buffardi, L. Brugières, P. Harker‐Murray, P.D. Cole, R.A. Drachtman, T. Manley, S. Francis, M. Sacchi, T. Leblanc

Institutions: Roswell Park Comprehensive Cancer Center, University College Hospital, Justus-Liebig-Universität Gießen, Centro di Riferimento Oncologico, Hôpital de la Timone, Johns Hopkins University, Johns Hopkins Hospital, Princess Máxima Center, Seattle Children's Hospital, Istituto Giannina Gaslini, Santobono Children's Hospital, Institut Gustave Roussy, Children's Hospital of Wisconsin, Rutgers Cancer Institute, Seagen (United States), Bristol-Myers Squibb (United States), Hôpital Robert-Debré

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2952743728

FWCI: 0.47

Cites:

Cited by: 3

Related to: 20